|
Volumn 100, Issue 4, 2007, Pages
|
VEGF165 gene-mediated arteriogenesis and cardioprotection in large mammals with acute myocardial infarction. Confirmation of previous results from other authors
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOVIRUS VECTOR;
PLASMID DNA;
VASCULOTROPIN 165;
CARDIOTONIC AGENT;
UNCLASSIFIED DRUG;
VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN;
VASCULOTROPIN A;
ANGIOGENESIS;
APOPTOSIS;
CELL PROLIFERATION;
CELL VIABILITY;
CYTOKINESIS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
GENE EXPRESSION;
GENE TRANSFER;
HEART INFARCTION;
HEART PROTECTION;
LETTER;
MITOSIS;
MITOSIS INDEX;
MYOBLAST;
NONHUMAN;
PRIORITY JOURNAL;
TISSUE REPAIR;
UPREGULATION;
VIRAL GENE THERAPY;
ANIMAL;
ARTERIOLE;
CYTOLOGY;
DOG;
GENE THERAPY;
GENETICS;
GROWTH, DEVELOPMENT AND AGING;
HEART MUSCLE CELL;
HUMAN;
METABOLISM;
METHODOLOGY;
NOTE;
PHYSIOLOGY;
ANIMALS;
ARTERIOLES;
CARDIOTONIC AGENTS;
DOGS;
GENE THERAPY;
HUMANS;
MYOCARDIAL INFARCTION;
MYOCYTES, CARDIAC;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 33947517101
PISSN: 00097330
EISSN: None
Source Type: Journal
DOI: 10.1161/01.RES.0000259103.78029.09 Document Type: Letter |
Times cited : (2)
|
References (5)
|